Eczacıbaşı İlaç Price
Last update:
Price History
Daily closing data sourced from Yahoo Finance.
Weekly Change
%-7.20
Monthly Change
%-6.82
Yearly Change
%72.94
Technical Outlook (Daily)
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 36.04 | Neutral |
| Stochastic %K (14) | 1.47 | Buy |
| CCI (20) | -106.76 | Buy |
| Momentum (10) | -9 | Sell |
| MACD (12,26) | -0.14 | Sell |
| Period | Value | Signal |
|---|---|---|
| MA5 | 82.57 | Sell |
| MA10 | 84.26 | Sell |
| MA20 | 84.68 | Sell |
| MA50 | 90.38 | Sell |
| MA100 | 103.73 | Sell |
| MA200 | 94.53 | Sell |
Technical indicators are calculated automatically from daily closing data; this is not investment advice.
- Open
- 82.95
- P/B
- 0.83
- EPS (TTM)
- -1.24
- Book Value
- 96.666
- Dividend Yield
- 1.82% (1.49)
- 50-Day Avg
- 90.379
- 200-Day Avg
- 94.6583
- Avg Volume (3M)
- 6.81M
- Shares Outstanding
- 685.26M
- Bid / Ask
- 79.95 / 80.00
- Exchange
- Istanbul
- Market State
- Closed
Company Data
Healthcare · Drug Manufacturers - Specialty & Generic · 967 employees
| Price/Book | 0.83 |
|---|---|
| Beta | 0.24 |
| Earnings Per Share (EPS) | -1.24 |
| 52-Week Change | %86.25 |
| Enterprise Value (EV) | 54.6B |
| Shares Outstanding | 685.3M |
| Last Dividend | 1.75 (May 6, 2026) |
| Insider Ownership | %81.23 |
| Institutional Ownership | %1.23 |
| Net Profit Margin | %-8.63 |
|---|---|
| Operating Margin | %-11.12 |
| Return on Equity (ROE) | %-1.45 |
| Return on Assets (ROA) | %-0.54 |
| Revenue Growth | %-1.3 |
| Debt/Equity | 5.88 |
| Current Ratio | 1.73 |
Company data is sourced from Yahoo Finance and may be delayed; this is not investment advice.
Eczacıbaşı İlaç News
- Pipeline Stock Face-Off: Is Enbridge or Oneok the Better Buy Right Now?
- Unhealthy air quality in California city as huge warehouse fire burns for 3rd day
- Amazon has a $360 work laptop that’s easy to set up for early Prime Day savings
- Fidelity, Vanguard and BlackRock are all adding annuities to 401(k) plans — betting retirees want pension-like income
- Raya relaxed despite Spain goalkeeper debate
- This Could Be the Easiest Way to Save for Retirement Despite Inflation
News is sourced from Yahoo Finance; headlines link to external sources.
What Is Eczacıbaşı İlaç?
Eczacıbaşı İlaç (ECILC) is a company share traded on Borsa İstanbul. This page shows the last trade price, daily change, and intraday movement for Eczacıbaşı İlaç. Data is updated during Borsa İstanbul session hours.
The Eczacıbaşı İlaç price is determined by supply and demand. The company's financial performance, sector dynamics, and the macro environment are the main determinants.
Factors Affecting the Eczacıbaşı İlaç Price
- Company quarterly financial results (EBITDA, net profit)
- Sector dynamics and the competitive environment
- Dividend policy and capital increase decisions
- Inclusion in/exclusion from BIST indices (liquidity effect)
- Macro conditions and the foreign ownership ratio
Frequently Asked Questions
- What is Eczacıbaşı İlaç?
- Eczacıbaşı İlaç (ECILC) is a publicly traded company on Borsa İstanbul. Its shares are bought and sold under the symbol "ECILC".
- What are the Eczacıbaşı İlaç trading hours?
- On Borsa İstanbul, pre-opening is 09:40-09:55 and continuous trading is 10:00-18:00 (lunch break 13:00-14:00).
- How is the Eczacıbaşı İlaç price determined?
- It is the last trade price at which buyer and seller are matched in the continuous auction system. The best bid and ask levels in the order book indicate liquidity.
- When does dividend distribution for Eczacıbaşı İlaç occur?
- Eczacıbaşı İlaç dividend distribution is determined by a general assembly decision; for past-year dividends you can follow the PDP (KAP) announcements.